Remove 2023 Remove BioTech Remove Healthcare Innovation Remove Pharmaceuticals
article thumbnail

Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion

Digital Health Global

The transaction is expected to close in the second half of 2023, subject to receipt of customary regulatory approvals and satisfaction of other customary closing conditions. For the full fourth quarter 2023, Baxter estimates the transaction to result in dilution of approximately $0.10

article thumbnail

JPM Healthcare Conference 2024

Digital Health Today

This has created opportunities for other organizations and events to lure the attendees and interest of healthcare innovators and executives. Francis Hotel is invite-only, but thousands of professionals from the healthcare and life sciences sector make the journey to San Francisco to participate in the adjacent events.